Quotient Sciences is a drug development and manufacturing accelerator that has operated in the pharmaceutical industry since 1990. The company provides integrated contract research, development, and manufacturing services to clients in the pharmaceutical and biotech sectors. It employs more than 1,000 experts across operations in the United States and the United Kingdom.
The company's technical work spans pharmaceutical development, clinical pharmacology, drug formulation development, clinical trials, and manufacturing. Its proprietary Translational Pharmaceutics® platform integrates clinical activities with real-time cGMP drug product manufacturing, a method designed to reduce the compartmentalisation common in drug development and shorten timelines.
With over 35 years of experience, Quotient Sciences describes its culture as grounded in scientific integrity, agility, and collaboration. The company has received industry awards recognising its work in the field.
